09 June 2000
Subclinical Rejection- a Potential Surrogate Marker for Chronic Rejection- May Be Diagnosed by Protocol Biopsy or Urine Spectroscopy
David Rush, Ray Somorjai, Roxanne Deslauriers, Anthony Shaw, John Jeffery, Peter NickersonAnn Transplant 2000; 5(2): 44-49 :: ID: 497525
Abstract
Chronic renal transplant rejection is a major cause of late transplant failure. About 50% of graft losses after the first year are due to patient death with a functioning transplant. In the survivors, about 50% to 80% of grafts are lost due to chronic rejection [1]. The design of studies to decrease the incidence of chronic rejection is hampered by the very large number of patients and the long-term follow up required [2]. The identification of early surrogate biomarkers for chronic rejection is therefore of considerable interest.
Keywords: subclinical rejection, protocol biopsies, urine spectroskopy
In Press
Original article
Impact of Preoperative Treatment on Donor Hepatic Steatosis in Living Donor Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.947772
Original article
Effects of Donor-Recipient Race Matching on Kidney Transplant SurvivalAnn Transplant In Press; DOI: 10.12659/AOT.947720
Most Viewed Current Articles
03 Jan 2023 : Original article 7,006
Impact of Autologous Stem Cell Transplantation on Primary Central Nervous System Lymphoma in First-Line and...DOI :10.12659/AOT.938467
Ann Transplant 2023; 28:e938467
15 Aug 2023 : Review article 6,993
Free-Circulating Nucleic Acids as Biomarkers in Patients After Solid Organ TransplantationDOI :10.12659/AOT.939750
Ann Transplant 2023; 28:e939750
16 May 2023 : Original article 6,746
Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections ...DOI :10.12659/AOT.939258
Ann Transplant 2023; 28:e939258
28 May 2024 : Original article 6,170
Effect of Dexmedetomidine Combined with Remifentanil on Emergence Agitation During Awakening from Sevoflura...DOI :10.12659/AOT.943281
Ann Transplant 2024; 29:e943281